Periodic Reporting for period 1 - MInfla-Tilc (Generation of therapeutic antibodies targeting type 2 Innate Lymphoid cells in asthma)

Asthma is a chronic respiratory disease that affects 300 million people worldwide and is expected to reach 400 million by 2025. Currently, there is no cure for this disease and only symptomatic treatments such as inhaled corticosteroids are available, but they are not always...